Question:
Took this quote from Antigenics Inc financial statement for 2007. Thought you guys might be interested.

"The first potential off-the-shelf application of our HSP technology, AG-707, is an investigational therapeutic vaccine product
candidate directed at the virus that causes genital herpes (herpes simplex virus-2, or HSV-2). We initiated a proof-of principle Phase 1
trial for AG-702, a monovalent (single-antigen) vaccine and predecessor to AG-707, in the fourth quarter of 2001. AG-707 is a
multivalent vaccine containing multiple synthetic HSV-2 peptides. Based on the results of completed toxicology studies and other
preclinical activities, we submitted to the FDA an investigational new drug application for AG-707 during the second quarter of 2005
and in October 2005, initiated a Phase 1 clinical trial of AG-707. We do not anticipate further developing AG-702, given that AG-707
has a potential to benefit a larger number of patients with genital herpes"

Heres the link http://72.14.205.104/search?q=cache:...lnk&cd=6&gl=us

Answer:
Great news, hopefull this one will work in men as well as women.

Answer:
I hope they come up with one for men too.They should make them for men and women.Everyone deserves to be protected .

Answer:
i would be willing to volunteer to be part of a clinical study!

Answer:
I as well.